Jaime Cheah earned her B.Sc in Biochemistry from McGill University, where she specialized in protein crystallography. She attended the Johns Hopkins School of Medicine in Baltimore, MD for her Ph.D. in Neuroscience, in the laboratory of Dr. Solomon Snyder, studying iron signaling in the brain. She moved back to the Boston area to do her postdoctoral fellowship at the Novartis Institutes for BioMedical Research and then joined the Broad Institute as a Research Scientist, where she led a team of researchers on a large-scale cancer cell line profiling project, correlating the genetics of cancer to drug responses. She then served as the Director of the High Throughput Sciences Facility at the Koch Institute of MIT for 8 years, where she oversaw a facility outfitted with state-of-the-art equipment and helped scientists design and execute their experiments in a larger, faster and more robust way. In 2022, she returned to the Broad Institute as the Director of Collaborative Screening in the Center for the Development of Therapeutics, where she collaborates with scientists to convert their bench-top research into development of patient therapies, utilizing high throughput drug screening as part of the process. She also is one of the managers of the Broad Institute’s Repurposing Hub and connects with a variety of researchers, including those rare disease foundations, to enable access to this valuable resource.
